BRIT1/MCPH1 Expression in Chronic Myeloid Leukemia and Its Regulation of the G2/M Checkpoint

Publisher： Karger

E-ISSN： 1421-9662|126|4|205-210

ISSN： 0001-5792

Source： Acta Haematologica, Vol.126, Iss.4, 2011-09, pp. : 205-210

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epigenetic inactivation of PLCD1 in chronic myeloid leukemia

By                

International Journal of Molecular Medicine, Vol. 30, Iss. 1, 2012-01 ,pp. : 179-184

Spandidos Publications

Access to resources Recommend Favorite

Assay of OAZ1 mRNA Levels in Chronic Myeloid Leukemia Combined with Application of Leukemia PCR Array Identified Relevant Gene Changes Affected by Antizyme

By  

Acta Haematologica, Vol. 131, Iss. 3, 2013-10 ,pp. : 141-147

Karger

Access to resources Recommend Favorite

Pretherapeutic Expression of the hOCT1 Gene Predicts a Complete Molecular Response to Imatinib Mesylate in Chronic-Phase Chronic Myeloid Leukemia

By  

Acta Haematologica, Vol. 127, Iss. 4, 2012-04 ,pp. : 228-234

Karger

Access to resources Recommend Favorite

Expression of a humanized single-chain variable fragment antibody targeting chronic myeloid leukemia cells in Escherichia coli and its characterization

By                

International Journal of Molecular Medicine, Vol. 29, Iss. 5, 2012-01 ,pp. : 939-945

Spandidos Publications

Access to resources Recommend Favorite

Longitudinal Study to Assess the Clinical Significance of MSI2 Expression in Chronic Myeloid Leukemia Patients

By  

Acta Haematologica, Vol. 136, Iss. 1, 2016-05 ,pp. : 62-64

Karger

Access to resources Recommend Favorite